|
1
|
Potters L, Steinberg M, Rose C, et al:
American Society for Therapeutic Radiology and Oncology and
American College of Radiology practice guidelines for the
performance of stereo-tactic body radiation therapy. Int J Radiat
Oncol Biol Phys. 60:1026–1032. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagata Y, Matsuo Y, Takayama K, et al:
Current status of stereotactic radiotherapy for lung cancer. Int J
Clin Oncol. 12:3–7. 2007. View Article : Google Scholar
|
|
3
|
Nagata Y, Negoro Y, Aoki T, et al:
Clinical outcomes of 3D conformal hypofractionated single high-dose
radiotherapy for one or two lung tumors using a stereotactic body
frame. Int J Radiat Oncol Biol Phys. 52:1041–1046. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakagawa K, Aoki Y, Tago M, Terahara A and
Ohtomo K: Megavoltage CT-assisted stereotactic radiosurgery for
thoracic tumors: original reseach in the treatment of thoracic
neoplasms. Int J Radiat Oncol Biol Phys. 48:449–457. 2000.
View Article : Google Scholar
|
|
5
|
Herfarth KK, Debus J, Lohr F, et al:
Stereotactic single-dose radiation therapy of liver tumors: results
of a phase I/II trial. J Clin Oncol. 19:164–170. 2001.PubMed/NCBI
|
|
6
|
Wulf J, Guckenberger M, Haedinger U, et
al: Stereotactic radiotherapy of primary liver cancer and hepatic
metastases. Acta Oncol. 45:838–847. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kavanagh BD, McGarry RC and Timmerman RD:
Extracranial radiosurgery (stereotactic body radiation therapy) for
oligometastases. Semin Radiat Oncol. 16:77–84. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koong AC, Christofferson E, Le QT, et al:
Phase II study to assess the efficacy of conventionally
fractionated radiotherapy followed by a stereotactic radiosurgery
boost in patients with locally advanced pancreatic cancer. Int J
Radiat Oncol Biol Phys. 63:320–323. 2005. View Article : Google Scholar
|
|
9
|
Deodato F, Macchia G, Grimaldi L, et al:
Stereotactic radiotherapy in recurrent gynecological cancer: a case
series. Oncol Rep. 22:415–419. 2009.PubMed/NCBI
|
|
10
|
Gerszten PC, Ozhasoglu C, Burton SA, et
al: CyberKnife frameless stereotactic radiosurgery for spinal
lesions: clinical experience in 125 cases. Neurosurgery. 55:89–98.
2004.PubMed/NCBI
|
|
11
|
Song Y, Zhang P, Wang P, et al: The
development of a novel radiation treatment modality-volumetric
modulated arc therapy. Conf Proc IEEE Eng Med Biol Soc.
2009:3401–3404. 2009.PubMed/NCBI
|
|
12
|
National Cancer Institute: Common
Terminology Criteria for Adverse Events 4.03 (CTCAE 4.03).
Available at: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htmAccessed
February 22, 2012.
|
|
13
|
Herfarth KK, Hof H, Bahner ML, et al:
Assessment of focal liver reaction by multiphasic CT after
stereotactic single-dose radiotherapy of liver tumors. Int J Radiat
Oncol Biol Phys. 57:444–451. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaplan EL and Meier P: Non-parametric
estimation from incomplete observations. J Am Statist Assoc.
53:457–481. 1985. View Article : Google Scholar
|
|
15
|
Lax I, Blomgren H, Näslund I and Svanström
R: Stereotactic radiotherapy of malignancies in the abdomen.
Methodological aspects Acta Oncol. 33:677–683. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blomgren H, Lax I, Näslund I and Svanström
R: Stereotactic high dose fraction radiation therapy of
extracranial tumors using an accelerator. Clinical experience of
the first thirty-one patients. Acta Oncol. 34:861–870. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hurkmans CW, Cuijpers JP, Lagerwaard FJ,
et al: Recommendations for implementing stereotactic radiotherapy
in peripheral stage IA non-small cell lung cancer: report from the
Quality Assurance Working Party of the randomised phase III ROSEL
study. Radiat Oncol. 4:12009. View Article : Google Scholar
|
|
18
|
National Comprehensive Cancer Network
(NCCN): Practice Guidelines in Oncology 2.2010-Non Small Cell Lung
Cancer.
|
|
19
|
Timmerman RD: An overview of
hypofractionation and introduction to this issue of seminars in
radiation oncology. Semin Radiat Oncol. 18:215–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morganti AG, Deodato F, Zizzari S, et al:
Complexity index (COMIX) and not type of treatment predicts
undetected errors in radiotherapy planning and delivery. Radiother
Oncol. 89:320–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Therasse P, Arbuck SG, Eisenhauer EA, et
al: New guidelines to evaluate the response to treatment in solid
tumors. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Young H, Baum R, Cremerius U, et al:
Measurement of clinical and subclinical response using
[18F]-fluorodeoxiglucose and Positron Emission Tomography: review
and 1999 EORTC recommendations. European Organisation for Research
and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer.
35:1773–1782. 1999.
|
|
23
|
Sutherland HJ, Walker P and Till JE: The
development of a method for determining oncology patients’
emotional distress using linear analogue scales. Cancer Nurs.
11:303–308. 1988.
|
|
24
|
Matuszak MM, Yan D, Grills I and Martinez
A: Clinical applications of volumetric modulated arc therapy. Int J
Radiat Oncol Biol Phys. 77:608–616. 2010.PubMed/NCBI
|
|
25
|
Kuijper IT, Dahele M, Senan S and Verbakel
WF: Volumetric modulated arc therapy versus conventional intensity
modulated radiation therapy for stereotactic spine radiotherapy: a
planning study and early clinical data. Radiother Oncol.
94:224–228. 2010. View Article : Google Scholar
|
|
26
|
McGrath SD, Matuszak MM, Yan D, Kestin LL,
Martinez AA and Grills IS: Volumetric modulated arc therapy for
delivery of hypofractionated stereotactic lung radiotherapy: A
dosimetric and treatment efficiency analysis. Radiother Oncol.
95:153–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Holt A, van Vliet-Vroegindeweij C, Mans A,
Belderbos JS and Damen EM: Volumetric-modulated arc therapy for
stereotactic body radiotherapy of lung tumors: a comparison with
intensity-modulated radiotherapy techniques. Int J Radiat Oncol
Biol Phys. 81:1560–1567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ong CL, Verbakel WF, Cuijpers JP, Slotman
BJ, Lagerwaard FJ and Senan S: Stereotactic radiotherapy for
peripheral lung tumors: a comparison of volumetric modulated arc
therapy with 3 other delivery techniques. Radiother Oncol.
97:437–442. 2010.PubMed/NCBI
|
|
29
|
Ma Y, Li M, Yin Y, et al: Hypofractionated
stereotactic radiotherapy for brain metastases: a dosimetric and
treatment efficiency comparison between volumetric modulated arc
therapy and intensity modulated radiotherapy. Technol Cancer Res
Treat. 9:499–507. 2010.
|
|
30
|
Mayo CS, Ding L, Addesa A, Kadish S,
Fitzgerald TJ and Moser R: Initial experience with volumetric IMRT
(RapidArc) for intracranial stereotactic radiosurgery. Int J Radiat
Oncol Biol Phys. 78:1457–1466. 2010.PubMed/NCBI
|
|
31
|
Scorsetti M, Mancosu P, Navarria P, et al:
Stereotactic body radiation therapy (SBRT) for adrenal metastases:
a feasibility study of advanced techniques with modulated photons
and protons. Strahlenther Onkol. 187:238–244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Palma DA, van Sörnsen de Koste J, Verbakel
WF, Vincent A and Senan S: Lung Density Changes After Stereotactic
Radiotherapy: A Quantitative Analysis in 50 Patients. Int J Radiat
Oncol Biol Phys. 81:974–978. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Palma DA, Senan S, Haasbeek CJ, Verbakel
WF, Vincent A and Lagerwaard F: Radiological and clinical
pneumonitis after stereotactic lung radiotherapy: a matched
analysis of three-dimensional conformal and volumetric-modulated
arc therapy techniques. Int J Radiat Oncol Biol Phys. 80:506–513.
2011.
|
|
34
|
Ong CL, Palma D, Verbakel WF, Slotman BJ
and Senan S: Treatment of large stage I–II lung tumors using
stereotactic body radiotherapy (SBRT): planning considerations and
early toxicity. Radiother Oncol. 97:431–436. 2010.
|
|
35
|
Subramanian S, Srinivas C, Ramalingam K,
et al: Volumetric modulated arc-based hypofractionated stereotactic
radiotherapy for the treatment of selected intracranial
arteriovenous malformations: dosimetric report and early clinical
experience. Int J Radiat Oncol Biol Phys. 82:1278–1284. 2012.
View Article : Google Scholar
|
|
36
|
Scorsetti M, Bignardi M, Alongi F, et al:
Stereotactic body radiation therapy for abdominal targets using
volumetric intensity modulated arc therapy with RapidArc:
feasibility and clinical preliminary results. Acta Oncol.
50:528–538. 2011.
|
